Adoptive Cellular Therapy using Cells Enriched for NKG2D(+)CD3(+)CD8(+)T Cells after Autologous Transplantation for Myeloma

The number of circulating lymphocytes on day 15 after transplantation correlates with improved survival in patients with myeloma, but the lymphocyte subset responsible is unknown. NKG2D is a natural killer (NK) cell activating receptor that mediates non-MHC restricted and TCR-independent cell lysis....

Full description

Saved in:
Bibliographic Details
Main Authors: Meehan, Kenneth R., Talebian, Laleh, Tosteson, Tor D., Hill, John M., Szczepiorkowski, Zbigniew, Sentman, Charles L., Ernstoff, Marc S.
Format: Artigo
Language:Inglês
Published: 2012
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3772513/
https://ncbi.nlm.nih.gov/pubmed/22975165
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2012.08.018
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items